Study of ATTR-01 for certain solid tumors
Part of Cancer clinical trials.
This trial tests a new treatment called ATTR-01 for people with certain types of solid tumors that have a specific protein (αvβ6 integrin) in high amounts. It is for those who have already tried standard treatments and need new options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old with a solid tumor that has a high level of a specific protein (αvβ6) on its surface.
- You have tried standard treatments for your cancer and they no longer work or you cannot tolerate them.
- You have a tumor that can be safely biopsied before and during treatment, and that has not been previously treated with radiation.
- Your cancer can be measured on scans (like CT or MRI) according to standard guidelines.
- You are able to take care of yourself (ECOG performance status 0 or 1).
- You are willing to follow hygiene rules to prevent spreading a genetically modified virus, and to use contraception if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, BioTTT001, given as a shot directly into tumors. It is for people with certain advanced solid tumors that have stopped responding to standard treatments or who have no other options.
This trial tests a new cell therapy called ReT01 for people with advanced solid tumors that have stopped responding to standard treatments. It uses your own immune cells from a tumor sample to fight the cancer.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
This trial tests a new drug called AVA6103 for people with certain advanced solid tumors that have not responded to standard treatments. The drug may help by targeting a protein on cancer cells and interfering with their ability to multiply.
This trial tests an investigational drug called AWT020 for people with advanced solid tumors that have grown after standard treatment. The goal is to see if AWT020 can help shrink or control the cancer, and it might be an option for you if other treatments haven't worked or aren't suitable.
This trial tests a new drug called AT1019 given together with targeted radiation (SBRT) and an immunotherapy drug for people with advanced solid tumors that are already being treated with immunotherapy. It aims to see if this combination can shrink or control tumors better.
Hear when a new Solid Tumor, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.